Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +3.88% | +1.90% | +1.90% |
Apr. 01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | Transcript : Quince Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+1.90% | 44.51M | |
+1.67% | 42.59B | |
+8.73% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+9.04% | 24.81B | |
-24.72% | 18.17B | |
+29.09% | 12.05B | |
-3.02% | 11.7B | |
+6.55% | 11.1B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- Canaccord Genuity Downgrades Cortexyme to Hold From Buy